Pregled bibliografske jedinice broj: 1040933
A non-invasive hidden-goal test for spatial orientation deficit detection in subjects with suspected mild cognitive impairment
A non-invasive hidden-goal test for spatial orientation deficit detection in subjects with suspected mild cognitive impairment // Journal of neuroscience methods, 332 (2020), 108547, 14 doi:10.1016/j.jneumeth.2019.108547 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1040933 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A non-invasive hidden-goal test for spatial
orientation deficit detection in subjects with
suspected mild cognitive impairment
(A non-invasive hidden-goal test for spatial
orientation deficit detection in subjects with
suspected mild
cognitive impairment)
Autori
Bažadona, Danira ; Fabek, Ivan ; Babić Leko, Mirjana ; Bobić Rasonja, Mihaela ; Kalinić, Dubravka ; Bilić, Ervina ; Raguž, Jakov Domagoj ; Mimica, Ninoslav ; Borovečki, Fran ; Hof, Patrick R. ; Šimić, Goran
Izvornik
Journal of neuroscience methods (0165-0270) 332
(2020);
108547, 14
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Alzheimer’s disease ; early diagnosis ; hidden-goal task ; mild cognitive impairment ; screening test ; spatial orientation
Sažetak
BACKGROUND: There is a need for highly sensitive and specific tests and biomarkers that would allow preclinical diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease (AD), which would also enable timely intervention. NEW METHOD: We have developed a new system (ALZENTIA) to help detect early MCI, mainly caused by AD. The system is based on a hidden-goal task (HGT) in which the human subject has to find a target that is not visible ; as such, the navigation is based on a previously memorized target position, in relation to the starting position (egocentric variant) and/or other navigational landmarks (allocentric variant of the task). We present our preliminary results obtained in 33 patients with MCI and 91 healthy controls (HC). RESULTS AND COMPARISON WITH EXISTING METHODS: Between-group differences in the average error measured in allocentric, egocentric, and combined allocentric- egocentric subtests were statistically significant in MCI compared to HC. The high negative predictive values suggested high discriminative capacity and diagnostic potential for the HGT test as a tool to detect subjects in healthy population who will progress to MCI. Considering the low sensitivity of the Mini-Mental Status Examination and Montreal Cognitive Assessment tests, we believe that HGT can improve early identification of MCI patients who will progress to AD. CONCLUSION: The HGT carried out with the ALZENTIA system proved to be a reliable screening test to identify individuals with MCI from an aging cohort.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
--IP-2014-09-9730 - Hiperfosforilacija, agregacija i transsinaptički prijenos tau proteina u Alzheimerovoj bolesti: analiza likvora i ispitivanje potencijalnih neuroprotektivnih spojeva (ALZTAUPROTECT) (Šimić, Goran) ( CroRIS)
HRZZ-IP-2019-04-3584
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče,
Klinički bolnički centar Zagreb
Profili:
Fran Borovečki
(autor)
Dubravka Kalinić
(autor)
Ninoslav Mimica
(autor)
Mihaela Bobić
(autor)
Ervina Bilić
(autor)
Mirjana Babić Leko
(autor)
Goran Šimić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE